Resection for Hepatocellular Carcinoma

Journal of Clinical and Experimental Hepatology

Volumn 4, Issue , 2014, Pages S90-S96

  Ramesh, Hariharan ^a  

^a Lakeshore Hospital and Research Center   (India)

Author keywords

Hepatocellular carcinoma; Liver cancer; Liver tumor; Resection; Surgery

Indexed keywords

ARTIFICIAL EMBOLISM; CANCER ADJUVANT THERAPY; CHEMOEMBOLIZATION; CHRONIC LIVER DISEASE; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER RESECTION; LIVER TRANSPLANTATION; PATIENT SELECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL PREDICTION; TUMOR ABLATION;

EID: 84928993587     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2014.07.002     Document Type: Review

References (48)

1. Grando-Lemaire V., Guettier C., Chevret S., Beaugrand M., Trinchet J.C. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999, 31(3):508-513.
2. Belghiti J., Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford) 2005, 7(1):42-49.
3. Landman M.P., Feurer I.D., Pinson C.W., Moore D.E. Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?. HPB (Oxford) 2011, 13(11):783-791.
4. Eguchi S., Kanematsu T., Arii S., et al. Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. Br J Surg 2011, 98(4):552-557.
5. Wolfort R.M., Papillion P.W., Turnage R.H., Lillien D.L., Ramaswamy M.R., Zibari G.B. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Int Surg 2010, 95(1):67-75.
6. Young A.L., Malik H.Z., bu-Hilal M., et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg 2007, 205(3):453-462.
7. Ikai I., Yamamoto Y., Yamamoto N., et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 2003, 12(1):65-75. ix.
8. Pawlik T.M., Poon R.T., Abdalla E.K., et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005, 137(4):403-410.
9. Wang B.W., Mok K.T., Liu S.I., et al. Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?. J Formos Med Assoc 2008, 107(8):616-626.
10. Ng K.K., Vauthey J.N., Pawlik T.M., et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005, 12(5):364-373.
11. Schindl M.J., Redhead D.N., Fearon K.C., Garden O.J., Wigmore S.J. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 2005, 54(2):289-296.
12. Teh S.H., Christein J., Donohue J., et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005, 9(9):1207-1215.
13. Hsu K.Y., Chau G.Y., Lui W.Y., Tsay S.H., King K.L., Wu C.W. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg 2009, 33(11):2412-2419.
14. Cucchetti A., Ercolani G., Vivarelli M., et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006, 12(6):966-971.
15. Lau H., Man K., Fan S.T., Yu W.C., Lo C.M., Wong J. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997, 84(9):1255-1259.
16. Lam C.M., Fan S.T., Lo C.M., Wong J. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 1999, 86(8):1012-1017.
17. Earl T.M., Chapman W.C. Conventional surgical treatment of hepatocellular carcinoma. Clin Liver Dis 2011, 15(2):353-370.
18. Teh S.H., Nagorney D.M., Stevens S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007, 132(4):1261-1269.
19. Farges O., Belghiti J., Kianmanesh R., et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003, 237(2):208-217.
20. Abulkhir A., Limongelli P., Healey A.J., et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008, 247(1):49-57.
21. Chua T.C., Liauw W., Saxena A., et al. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int 2010, 30(2):166-174.
22. Hwang S., Lee S.G., Ko G.Y., et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg 2009, 249(4):608-616.
23. Yoo H., Kim J.H., Ko G.Y., et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 2011, 18(5):1251-1257.
24. Chen H., Merchant N.B., Didolkar M.S. Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality. J Gastrointest Surg 2000, 4(2):162-167.
25. Man K., Fan S.T., Ng I.O., Lo C.M., Liu C.L., Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997, 226(6):704-711.
26. Dahiya D., Wu T.J., Lee C.F., Chan K.M., Lee W.C., Chen M.F. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010, 147(5):676-685.
27. Shi M., Guo R.P., Lin X.J., et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007, 245(1):36-43.
28. Poon R.T., Fan S.T., Ng I.O., Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 2000, 231(4):544-551.
29. Pamecha V., Gurusamy K.S., Sharma D., Davidson B.R. Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HPB (Oxford) 2009, 11(4):275-281.
30. Gurusamy K.S., Pamecha V., Sharma D., Davidson B.R. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev 2009, (1):CD006880.
31. Liu C.L., Fan S.T., Cheung S.T., Lo C.M., Ng I.O., Wong J. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 2006, 244(2):194-203.
32. Lai E.C., Fan S.T., Lo C.M., Chu K.M., Liu C.L. Anterior approach for difficult major right hepatectomy. World J Surg 1996, 20(3):314-317.
33. Wu T.J., Wang F., Lin Y.S., Chan K.M., Yu M.C., Lee W.C. Right hepatectomy by the anterior method with liver hanging versus conventional approach for large hepatocellular carcinomas. Br J Surg 2010, 97(7):1070-1078.
34. Belghiti J. Editorial perspective: resection of large hepatocellular carcinoma using combination of liver hanging maneuver and anterior approach. World J Surg 2010, 34(8):1879-1880.
35. Chen X.P., Zhang W.G., Lau W.Y., Qiu F.Z. Right hepatectomy using the liver double-hanging maneuver through the retrohepatic avascular tunnel on the right of the inferior vena cava. Surgery 2008, 144(5):830-833.
36. Jarnagin W., Chapman W.C., Curley S., et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010, 12(5):302-310.
37. Tiong L., Maddern G.J. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011, 98(9):1210-1224.
38. Desiderio J., Trastulli S., Pasquale R., et al. Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbecks Arch Surg 2013, 398(1):55-62.
39. Mittler J., McGillicuddy J.W., Chavin K.D. Laparoscopic liver resection in the treatment of hepatocellular carcinoma. Clin Liver Dis 2011, 15(2):371-384.
40. Araki K., Conrad C., Ogiso S., Kuwano H., Gayet B. Intraoperative ultrasonography of laparoscopic hepatectomy: key technique for safe liver transection. J Am Coll Surg 2013, (13):10.
41. Long T.C., Bac N.H., Thuan N.D., Dat L.T., Viet D.Q., Chuong L.C. Laparoscopic liver resection: 5-year experience at a single center. Surg Endosc 2014, 28(3):796-802.
42. Reggiani P., Antonelli B., Rossi G. Robotic surgery of the liver: Italian experience and review of the literature. Ecancermedicalscience 2013, 7:358.
43. Fan S.T., Poon R.T., Yeung C., et al. Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria. Br J Surg 2011, 98(9):1292-1300.
44. Lee Y.H., Hsu C.Y., Huang Y.H., et al. Alpha-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma. J Gastrointest Surg 2013, 17(4):730-738.
45. Nagano H., Kobayashi S., Marubashi S., et al. Combined IFN-alpha and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus. Exp Ther Med 2013, 5(1):3-10.
46. Riaz I.B., Riaz H., Riaz T., et al. Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2012, 12:170.
47. Kishi Y., Hasegawa K., Sugawara Y., Kokudo N. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol 2011, 2011:728103.
48. Liu F., Wei Y., Wang W., et al. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection. PLoS One 2012, 7(11):e48932.